RxWare

Wilmington, DE · Founded 2013 · Privately Held (backing)

Developer of a digital platform designed for connecting patients with essential services. RxWare is based in Wilmington, DE and was founded in 2013. Its last reported valuation was $19.5 million in Jan 2020. It has raised $13.8 million across 2 recorded rounds; the latest was a $6.1 million early-stage round in Aug 2025.

Last reported valuation
$19.5M
Oct 2026
Priced at
—
Total raised
$13.8M
Last round
Early Stage VC
Aug 2025
What is RxWare worth?
$19.5Mlast reported valuation · Oct 2026

RxWare's last reported valuation, Jan 2020. Nothing priced has surfaced since.

Free account
More of RxWare with a free account
  • ·The complete investor list: 18 names
  • ·Watch RxWare: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

RxWare funding history

2 rounds
DateRoundRaisedPost-money
Aug 2025Early Stage VC$6.1M▮
Apr 2024Seed Round$700K▮
Unlock post-money valuations

Membership and data by Private Market View

RxWare valuation

RxWare's last reported valuation was $19.5 million in Jan 2020. No priced round, secondary trade or fund mark has surfaced since.

How much has RxWare raised?

RxWare has raised $13.8 million in total; 2 of its rounds are on record. The largest on record was a $700,000 seed round in Apr 2024; the most recent was a $6.1 million early-stage round in Aug 2025.

RxWare has filed 3 Form Ds with the SEC since 2024, most recently in Aug 2025 ($6.1 million sold to 12 investors).

How RxWare's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For RxWare, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about RxWare

What is RxWare worth?
RxWare is valued at $19.5M as of Oct 2026. RxWare's last reported valuation, Jan 2020. Nothing priced has surfaced since.
How much has RxWare raised?
RxWare has raised $13.8M in total funding across 2 recorded rounds.
When did RxWare last raise?
RxWare last raised in Aug 2025 (Early Stage VC), raising $6.1M.